Technical Analysis for HARP - Harpoon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 14.3 1.63% 0.23
HARP closed up 1.63 percent on Thursday, February 14, 2019, on 74 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical HARP trend table...

Date Alert Name Type % Chg
Feb 14 New 52 Week Closing High Bullish 0.00%
Feb 14 Hot IPO Pullback Bullish Swing Setup 0.00%

Older signals for HARP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. It is involved in developing HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer; and HPN536 for the treatment of ovarian cancer and other mesothelin expressing tumors, as well as other products targeting tumor-associated antigens for the treatment of multiple myeloma and small-cell lung cancer. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Medicine Cancer Medical Specialties Diseases Oncology Immunotherapy Prostate Cancer Cancer Immunotherapy Ovarian Cancer Multiple Myeloma Tumors Proteins Treatment Of Ovarian Cancer Metastatic Castration Resistant Prostate Cancer Neuvenge
Is HARP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.1495
52 Week Low 13.25
Average Volume 183,921
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.95
Resistance 3 (R3) 14.90 14.64 14.84
Resistance 2 (R2) 14.64 14.48 14.66 14.80
Resistance 1 (R1) 14.47 14.37 14.56 14.52 14.77
Pivot Point 14.21 14.21 14.25 14.23 14.21
Support 1 (S1) 14.04 14.05 14.13 14.09 13.83
Support 2 (S2) 13.78 13.94 13.80 13.80
Support 3 (S3) 13.61 13.78 13.76
Support 4 (S4) 13.66